‘Diet and lifestyle’ in the management of dyslipidaemia and prevention of CVD - Understanding the level of knowledge and interest of European Atherosclerosis Society members

2020-12-1

How registers could enhance knowledge and characterization of genetic dyslipidaemias: The experience of the LIPIGEN in Italy and of other networks for familial hypercholesterolemia

2020-12-1

Prevalence and relationship between metabolic syndrome and risk of cardiovascular disease: Evidence from two population-based studies

2020-12-1

Lipid-lowering therapy and low-density lipoprotein cholesterol goal achievement in patients with acute coronary syndromes: The ACS patient pathway project

2020-12-1

Improving lipid management in patients with acute coronary syndrome: The ACS Lipid EuroPath tool

2020-12-1

Lipid Clinics Network. Rationale and design of the EAS global project

2020-12-1

Title page

2020-12-1

Hypercholesterolemia and cardiovascular disease: What to do before initiating pharmacological therapy

2020-12-1

The prevalence of cardiovascular risk factors and cardiovascular disease among primary care patients in Poland: results from the LIPIDOGRAM2015 study

2020-12-1

Implementation of clinical practices and pathways optimizing ACS patients lipid management: Focus on eight European initiatives

2020-12-1

Hypercholesterolemia and cardiovascular disease: Focus on high cardiovascular risk patients

2020-12-1

Similarities and differences between European and American guidelines on the management of blood lipids to reduce cardiovascular risk

2020-12-1

ACS in CKD Patients

2020-4-1

Trends in Early Invasive Management of Egyptian Patients with Acute Coronary Syndrome; Data from The Cross-Sectional Cardiorisk Project

2020-3-27

Exercise-Based Cardiac Rehabilitation in Patients with Acute Coronary Syndrome

2020-3-27

Clinical Characteristics and Short Term Outcome of Multi-Vessel Coronary Artery Disease Patients Presented with AMI- Single Center Experience

2020-3-27

Cardiovascular Predictors of Stroke in Patients with Sinus Rhythm Versus Patients with Atrial Fibrillation in Suez Canal University Hospital

2020-3-27

Correlation Between Epicardial Fat Thickness Assessed by Echocardiography and Coronary Artery Disease Severity in Patients Attending Suez Canal University Hospital

2020-3-27

Diagnostic Accuracy of 256 Slices Computed Tomography Coronary Angiography in Post CABG Egyptian Patients

2020-3-27

Egyptian Association of Vascular Biology and Atherosclerosis (EAVA) consensus on the usage of pro protein convertase subtilisin/kexin type 9 (PCSK9) inhibitors

2020-3-26

Serum Bilirubin as Predictor of Infarct-Related Artery Patency, and In-Hospital Outcomes for ST- Elevation Myocardial Infarction and In-Hospital Outcomes Following Percutaneous Coronary Intervention

2020-3-26

Apheresis as emerging treatment option in severe early onset preeclampsia

2019-12-1

Optical coherence tomography of retinal and choroidal layers in patients with familial hypercholesterolaemia treated with lipoprotein apheresis

2019-12-1

Experience with proprotein convertase subtilisin/kexine type 9 inhibitors (PCSK9i) in patients undergoing lipoprotein apheresis

2019-12-1

Homozygous familial hypercholesterolaemia in childhood – The first case report in Southeast Europe

2019-12-1

Cardiovascular risk factors in patients with premature cardiovascular events attending the University of Dresden Lipid Clinic

2019-12-1

A complicated pregnancy in homozygous familial hypercholesterolaemia treated with lipoprotein apheresis: A case report

2019-12-1

Statin-induced muscular side effects at rest and exercise – An anatomical mapping

2019-12-1

Actual situation of lipoprotein apheresis in patients with elevated lipoprotein(a) levels

2019-12-1

Serum uric acid and left ventricular geometry pattern in obese children

2019-12-1

One year follow-up of patients with reduced left ventricular ejection fraction (LVEF) on lipoprotein apheresis

2019-12-1

Kidney and liver are the main organs of expression of a key metabolic enzyme alanine:glyoxylate aminotransferase 2 in humans

2019-12-1

Short- and long-term effects of lipoprotein apheresis on plasma hormones in patients with therapy-resistant dyslipidemia

2019-12-1

Lipoprotein(a) – Marker for cardiovascular risk and target for lipoprotein apheresis

2019-12-1

Influence of lipoprotein apheresis on circulating plasma levels of miRNAs in patients with high Lp(a)

2019-12-1

ADMA elevation does not exacerbate development of diabetic nephropathy in mice with streptozotocin-induced diabetes mellitus

2019-12-1

Lipoprotein apheresis in Germany – Still more commonly indicated than implemented. How can patients in need access therapy?

2019-12-1

Variants Of Uncertain Significance: Higher Than Average Results In Yorkshire And Humberside For Familial Hypercholesterolaemia

2019-10-1

Three years experience of lomitapide therapy in the uk

2019-10-1

Lipoprotein (a) and carotid intima media thickness as an adjunct to CVD risk assessment in patients with familial hypercholesterolemia or high cardiovascular risk

2019-10-1

African ApoE2/3 diabetic patients seldom develop dyslipidaemia

2019-10-1

Title Page

2019-10-1

Familial hyercholesterolaemia service –a synopsis from gloucestershire lipid clinics

2019-10-1

Identifying 25% Of Individuals With Fh In The Next 5 Years: Is This An Achievable Target?

2019-9-17

Test performance of genetic testing in familial hypercholesterolaemia in a local lipid clinic

2019-9-17

Lipoprotein (a) in patients with familial hypercholesterolaemia

2019-9-17

12 Month Review Of Lipid / Cholesterol Testing Throughout North Wales (Betsi Cadwaladr University Health Board) – An Adjunct For Familial Hypercholesterolaemia (Fh) Case Finding

2019-9-17

Screening for lald in lipid clinics

2019-9-17

Age Adjusted Welsh Criteria For Selecting Patients For Familial Hypercholesterolaemia (Fh) Genetic Testing

2019-9-17

Evolocumab therapy and a possible association with skin reactions

2019-9-17